These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8710463)
1. [Clinical evaluation of power Doppler sonography for the diagnosis of hepatocellular carcinoma]. Ohishi H; Hirai T; Yamada R; Hirohashi S; Honda N; Sakaguchi H; Matsuo N; Uchida H Nihon Igaku Hoshasen Gakkai Zasshi; 1996 May; 56(6):399-404. PubMed ID: 8710463 [TBL] [Abstract][Full Text] [Related]
2. [Therapeutic effect of TAE in patients with hepatocellular carcinoma using color Doppler imaging with intravenous ultrasound contrast agent]. Kimura M; Sato M; Shioyama Y; Hagihira T; Horihata K; Terada M; Kishi K; Tanaka K; Kawai N Nihon Igaku Hoshasen Gakkai Zasshi; 2000 May; 60(6):320-3. PubMed ID: 10860382 [TBL] [Abstract][Full Text] [Related]
3. Differential diagnosis of small hepatocellular carcinoma and adenomatous hyperplasia with power Doppler sonography. Koito K; Namieno T; Morita K AJR Am J Roentgenol; 1998 Jan; 170(1):157-61. PubMed ID: 9423624 [TBL] [Abstract][Full Text] [Related]
4. Power Doppler sonography: evaluation of hepatocellular carcinoma after treatment with transarterial embolization or percutaneous ethanol injection therapy. Koito K; Namieno T; Ichimura T; Hirokawa N; Syonai T; Hareyama M; Katsuramaki T; Hirata K; Nishi M AJR Am J Roentgenol; 2000 Feb; 174(2):337-41. PubMed ID: 10658701 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the intratumoral vasculature of hepatocellular carcinoma by power doppler sonography: advantages and disadvantages versus conventional color doppler sonography. Kubota K; Hisa N; Fujiwara Y; Fukumoto M; Yoshida D; Yoshida S Abdom Imaging; 2000; 25(2):172-8. PubMed ID: 10675460 [TBL] [Abstract][Full Text] [Related]
6. Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US. Lencioni R; Pinto F; Armillotta N; Bartolozzi C Radiology; 1996 Nov; 201(2):353-8. PubMed ID: 8888222 [TBL] [Abstract][Full Text] [Related]
8. [Usefulness of CO2 US angiography in treating hepatocellular carcinoma]. Irie T; Yamada T; Ganaha F; Ujita M; Ishii C; Tada S Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jun; 58(7):338-42. PubMed ID: 9711072 [TBL] [Abstract][Full Text] [Related]
9. Color Doppler sonography of hepatocellular carcinoma before and after treatment by transcatheter arterial embolization. Tanaka K; Inoue S; Numata K; Takamura Y; Takebayashi S; Ohaki Y; Misugi K AJR Am J Roentgenol; 1992 Mar; 158(3):541-6. PubMed ID: 1310826 [TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US. Bartolozzi C; Lencioni R; Ricci P; Paolicchi A; Rossi P; Passariello R Radiology; 1998 Nov; 209(2):387-93. PubMed ID: 9807563 [TBL] [Abstract][Full Text] [Related]
11. Power versus conventional color Doppler sonography: comparison in the depiction of vasculature in liver tumors. Choi BI; Kim TK; Han JK; Chung JW; Park JH; Han MC Radiology; 1996 Jul; 200(1):55-8. PubMed ID: 8657945 [TBL] [Abstract][Full Text] [Related]
12. Validation of preclinical multiparametric imaging for prediction of necrosis in hepatocellular carcinoma after embolization. Braren R; Altomonte J; Settles M; Neff F; Esposito I; Ebert O; Schwaiger M; Rummeny E; Steingoetter A J Hepatol; 2011 Nov; 55(5):1034-40. PubMed ID: 21354233 [TBL] [Abstract][Full Text] [Related]
13. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings. Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882 [TBL] [Abstract][Full Text] [Related]
14. Color Doppler sonography for evaluating response to transcatheter arterial embolization and percutaneous ethanol injection therapy and for detecting recurrence of hepatocellular carcinoma. Shirato K; Numata K; Mitsui K; Kitamura T; Morita K; Saito S; Morimoto M; Kiba T; Okazaki H; Tanaka K; Sekihara H J Ultrasound Med; 2000 Dec; 19(12):807-14; quiz 815-6. PubMed ID: 11127004 [TBL] [Abstract][Full Text] [Related]
15. [Usefulness of enhanced US by CO2 microbubbles for segmental-subsegmental TAE for hepatocellular carcinoma]. Ohno K; Fujita M; Nakamura T; Sato O; Maeda T Nihon Rinsho; 1998 Apr; 56(4):994-1000. PubMed ID: 9577623 [TBL] [Abstract][Full Text] [Related]
16. [Transcatheter arterial embolization of hepatocellular carcinoma using CO2-US]. Miyajima Y; Sakaguchi S; Tohara K Nihon Rinsho; 1998 Apr; 56(4):990-3. PubMed ID: 9577622 [TBL] [Abstract][Full Text] [Related]
17. Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma. Sumi S; Yamashita Y; Mitsuzaki K; Yamamoto H; Urata J; Nishiharu T; Takahashi M AJR Am J Roentgenol; 1999 Jan; 172(1):67-71. PubMed ID: 9888742 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of hepatocellular carcinoma by segmental SMANCS Lipiodol-TAE]. Hayashi T; Uchida H; Matsuo N; Sakaguchi H; Anai H; Tanaka T; Yamamoto T; Ooue S; Yoshioka T; Makutani S; Oishi H Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():116-24. PubMed ID: 9512699 [TBL] [Abstract][Full Text] [Related]
19. Visualization of blood flow in hepatic vessels and hepatocellular carcinoma using B-flow sonography. Furuse J; Maru Y; Mera K; Sumi H; Yoshino M; Yokoyama Y; Hashimoto H; Ejiri A J Clin Ultrasound; 2001 Jan; 29(1):1-6. PubMed ID: 11180178 [TBL] [Abstract][Full Text] [Related]
20. [Advantages and disadvantages of L-TAE in diagnosis and treatment of hepatocellular carcinoma]. Shimamura Y; Ishii M; Shima Y; Takenaka H; Taniguchi H; Watanabe H; Kitai S; Sugai S; Takahashi A; Kitaya T Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2535-9. PubMed ID: 2843119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]